That’s great, thank you
16.10.2025 14:43
👍 0
🔁 0
💬 0
📌 0
That’s great, thank you
@robertblaser.bsky.social
Are medicare claims still on hold ? From my understanding it was only for 14 days from
oct 1 but the below newsletter suggests continuing hold on claims
www.cms.gov/training-edu...
well written; as a kidney doc I would just not agree that protein is bad for your kidneys
Paradoxical Inadequate Parathyroid Hormone Secretion Secondary to Severe Hypomagnesaemia
#nephsky
www.kidneymedicinejournal.org/article/S259...
When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases
doi.org/10.1093/ndt/...
the BAASIS - a simple self assessement tool - predicts clinically relevant non-adherence in kidney TX patients
academic.oup.com/ndt/advance-...
Treatment of patients with #IgAnephropathy: a call for a new paradigm
doi.org/10.1016/j.kint.2025.01.014
#OpenAccess #NephSky #MedSky #SkyNeph #IgAN #KIReview #kidneydisease
If you still feel unsure about the potential of this discovery, we found a beautiful infographic summarizing future directions for MVI in kidney transplantation #NephJC
www.frontierspartner...
T2n: #NephJC
⚡⚙️ Higher Banff g and ptc scores = higher risk for:
🔥AMR development
📈Glomerulopathy progression
🔮Histologic scores still tell the future
Agreed, and the further phenotyping will help lead to treatments for AMR. Kidney transplant physicians need more tools to preserve kidney transplants. The SONG initiative showed that kidney transplant recipients feared going on dialysis more than dying #nephjc
Organ Donation Message - Initiative of the BCCI and Indian Cricket Team
@isn-india.bsky.social @theisn.org
Are these recorded? Would love to listen to them at a later time
Thank you
Is there any comparative study regarding outcomes - for eg long term patency/ maturation rates between endovascular avf and surgically created fistula?
The dialysis industrial complex !! 😎😎
Thank you - hopefully Phosphate study will give some answers
While we are on this topic- is there any study that shows better outcomes by targeting Pth to less than a certain level?
So - will there be another study or do we say hi vs lo doesn’t matter and hopefully don’t have to force pts to swallow extra pills and maybe eat better ?
When Shawn's prom date bailed on him at the last minute for "a better offer" he took Elena instead. He didn't know that 35 years later Elena would be by his side again, this time as a living kidney donor.
If there was a NNT for AVF or in this case - the number needed to create (NNC)- what would that be?
it’s amazing how motivated all patients are to avoid/minimize time on dialysis- we should harness this motivation for their benefit- however if they remain on dialysis i always ask them what we can do to fit dialysis to their lifestyle not fit their lifestyle to dialysis-
Pt choices matter
Agree- CVC is not long term but if they have potential donors it not only avoids long term CVC, multiple procedures for AV access creation and patency maintenance but long term dialysis- of course if no viable donor and on wait list then AVf would be the way to go
This is great, will certainly look into it
Do your patients use this device to mitigate infection: www.cathdryglobal.com it's ideal for PD access, but works well w/ CVC access too.
Learned about it last week in @asnkidney.bsky.social webinar cc: @roy-chaudhury.bsky.social from a caregiver of a partner who has been on all dialysis modalities.
For younger pts I start with a CVC and refer them asap for txp eval. They are highly motivated and usually have potential living donors. Have several folks who have undergone Ldtxp and were able to avoid AV access surgery-trying to avoid cookie cutter medicine - the current paradigm of dialysis care
agree that AVF is the preferred access but really need to go away from diktats such as fistula first. need to individualize access. quality of life and patient preferences matter!! we all have pts who are doing just fine with a CVC.
Check out this #kidneystrong love story and get inspired to join the fight against kidney disease on #NationalDonorDay.
How can we forget - “continue to trend labs and monitor strict Is and Os”
😂😂
Contrary to popular- (ahem, cardiology bias)- opinion, it is unlikely that hypertension is causal of chronic kidney disease: academic.oup.com/ndt/advance-... #openaccess
Classic editorial this week from the #NephSky expert, Dr. Agarwal!!, 👀🤓🙏💛
Well the study was funded by and quite a few authors are affiliated with the drug manufacturer ….. so.. of course the conclusion is that drug innovation is stifled
Almost all the CKCC “value” based companies in nephrology are also owned by Private Equity 😏. This is a nice table I found on linkedin. I wonder who the “value” is for 🙃
